ARTICLE | Company News
Achillion management update
June 3, 2013 7:00 AM UTC
Achillion Pharmaceuticals Inc. (NASDAQ:ACHN), New Haven, Conn. Business: Infectious Transitioned: President of R&D and CSO Milind Deshpande to president, CEO and a director; he succeeds Michael Kishba...